BIM
ICPT

BlackRock Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

BlackRock Investment Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$878K Buy
8,083
+1,557
+24% +$185K ﹤0.01% 2768
2016
Q3 		$1.07M Buy
6,526
+116
+2% +$18.3K ﹤0.01% 2620
2016
Q2 		$915K Buy
6,410
+435
+7% +$63.4K ﹤0.01% 2697
2016
Q1 		$768K Sell
5,975
-9,183
-61% -$1.08M ﹤0.01% 2658
2015
Q4 		$2.26M Buy
15,158
+88
+0.6% +$14.9K ﹤0.01% 1987
2015
Q3 		$2.5M Sell
15,070
-986
-6% -$217K ﹤0.01% 1906
2015
Q2 		$3.88M Buy
16,056
+5,045
+46% +$1.34M ﹤0.01% 1705
2015
Q1 		$3.1M Buy
11,011
+6,812
+162% +$1.48M ﹤0.01% 1723
2014
Q4 		$655K Sell
4,199
-110
-3% -$20.3K ﹤0.01% 2836
2014
Q3 		$1.02M Sell
4,309
-124
-3% -$31.6K ﹤0.01% 2513
2014
Q2 		$1.05M Sell
4,433
-15,358
-78% -$4.05M ﹤0.01% 2572
2014
Q1 		$6.53M Buy
19,791
+113
+0.6% +$38.1K 0.01% 1197
2013
Q4 		$1.34M Sell
19,678
-86
-0.4% -$4.97K ﹤0.01% 2292
2013
Q3 		$1.36M Buy
19,764
+3,356
+20% +$166K ﹤0.01% 2226
2013
Q2 		$736K Buy
+16,408
New +$561K ﹤0.01% 2585

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

BlackRock Investment Management's ICPT Position: Q4 2016 in Review

BlackRock Investment Management increased its Intercept Pharmaceuticals, Inc. (ICPT) stake by 24% in Q4 2016, buying an estimated $185K and bringing the position to 8,083 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #2768.

BlackRock Investment Management first reported a position in ICPT in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.53M in Q1 2014. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

  • BlackRock Investment Management held 8,083 shares of Intercept Pharmaceuticals, Inc. worth $878K as of Q4 2016.
  • BlackRock Investment Management bought 1,557 Intercept Pharmaceuticals, Inc. shares in Q4 2016, an estimated $185K.
  • Intercept Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2768 holding.
  • BlackRock Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $6.53M in Q1 2014.
  • 159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.